APOA5 and metabolic syndrome: Individuals with G/G genotype for APOA5 (rs662799) polymorphisms were significantly associated with an increased likelihood of developing dyslipidemia upon both univariate [OR = 3.54, 95% CI(1.27–10.25; p = 0.0208)] and multivariate [OR = 2.38, 95% CI(1.06–6.54; p = 0.0093)] logistic regression analyses holding other variables constant.